Seena Tabibi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Seena Tabibi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Carlos J. Suarez
1 shared publicationElizabeth Morency
Department of Pathology Northwestern University Feinberg School of Medicine Chicago Illinois
1 shared publication- Guliz A. Barkan
Department of Pathology and Laboratory Medicine Loyola University Healthcare System Maywood Illinois USA
1 shared publication - Levent Trabzonlu
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois
1 shared publication - Lucy Jager
Department of Pathology Feinberg School of Medicine, Northwestern University Chicago Illinois USA
1 shared publication Margaret L. Compton
Department of Pathology, Microbiology, and Immunology Vanderbilt University Medical Center Nashville Tennessee
1 shared publication
Latest Publications
- Open Access
- 12 June 2025
- Published by Elsevier in Human Pathology Reports
- Vol. 41
Paradoxical cadherin-catenin immunostaining in a case of invasive mammary carcinoma with ductal and lobular differentiation: A molecular correlation
- 12 June 2025
- Published by Elsevier in Human Pathology Reports
- Vol. 41
Open AccessParadoxical cadherin-catenin immunostaining in a case of invasive mammary carcinoma with ductal and lobular differentiation: A molecular correlation
- Open Access
- 4 March 2022
- Published by Wiley in Cancer Cytopathology
- Vol. 130 (6) , 423-432
Adrenal gland cytology reporting: a multi‐institutional proposal for a standardized reporting system
BACKGROUND: With the development of new technologies and the changing patient profiles, cytopathology departments receive increasing numbers of adrenal gland cytology specimens. In this study, the authors analyzed archival adrenal gland cytology cases and attempted to implement a diagnostic reporting system.DESIGN: Retrospective electronic medical record search was performed for adrenal gland cytology specimens in seven tertiary care centers. The cytology diagnoses were grouped in 7 categories: nondiagnostic, nonneoplastic, benign adrenal cortical elements (BACE), primary neoplasm of noncortical origin (NONC), atypia of undetermined significance (AUS), suspicious for malignancy (SM), and malignant (MAL). If available, histopathology results of concurrent and/or follow‐up biopsies and/or resections were documented.RESULTS: A total of 473 adrenal gland cytology cases were included. BACE cases comprised 21.8%, whereas MAL cases were 57.5% of all cases. For BACE and MAL categories, there were 100% and 98.9% correlation, respectively, in the cases with histopathology follow‐up. Six of 10 NONC cases had histopathology diagnoses and there were 3 pheochromocytomas and 3 schwannomas. Twenty‐one AUS cases had histology follow‐up and 10 (47.6%) of them were malignant. Six cases of SM had histopathology follow‐up, and all of them were malignant on the follow‐up.CONCLUSIONS: The authors propose a 7‐tier diagnostic scheme for adrenal gland cytology. The risk of malignancy was 98.9% in MAL cases (87/88) in the cohort. The only case with discordance was reported as “adrenal cortical adenoma with marked atypia”' on resection. There was no difference between endoscopic ultrasound‐guided and percutaneous methods. Further studies are needed to validate and make this approach universal.;
- 4 March 2022
- Published by Wiley in Cancer Cytopathology
- Vol. 130 (6) , 423-432
Open AccessAdrenal gland cytology reporting: a multi‐institutional proposal for a standardized reporting system
BACKGROUND: With the development of new technologies and the changing patient profiles, cytopathology departments receive increasing numbers of adrenal gland cytology specimens. In this study, the authors analyzed archival adrenal gland cytology cases and attempted to implement a diagnostic reporting system.DESIGN: Retrospective electronic medical record search was performed for adrenal gland cytology specimens in seven tertiary care centers. The cytology diagnoses were grouped in 7 categories: nondiagnostic, nonneoplastic, benign adrenal cortical elements (BACE), primary neoplasm of noncortical origin (NONC), atypia of undetermined significance (AUS), suspicious for malignancy (SM), and malignant (MAL). If available, histopathology results of concurrent and/or follow‐up biopsies and/or resections were documented.RESULTS: A total of 473 adrenal gland cytology cases were included. BACE cases comprised 21.8%, whereas MAL cases were 57.5% of all cases. For BACE and MAL categories, there were 100% and 98.9% correlation, respectively, in the cases with histopathology follow‐up. Six of 10 NONC cases had histopathology diagnoses and there were 3 pheochromocytomas and 3 schwannomas. Twenty‐one AUS cases had histology follow‐up and 10 (47.6%) of them were malignant. Six cases of SM had histopathology follow‐up, and all of them were malignant on the follow‐up.CONCLUSIONS: The authors propose a 7‐tier diagnostic scheme for adrenal gland cytology. The risk of malignancy was 98.9% in MAL cases (87/88) in the cohort. The only case with discordance was reported as “adrenal cortical adenoma with marked atypia”' on resection. There was no difference between endoscopic ultrasound‐guided and percutaneous methods. Further studies are needed to validate and make this approach universal.;
- Open Access
- 15 July 2020
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 35 (9) , 827-835
Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients
In the 5 months since initial reports of COVID-19 came to light, the death toll due to SARS-CoV-2 has rapidly increased. The morbidity and mortality of the infection varies based upon patient age, comorbid conditions, viral load, and the availability of effective treatments. Findings from limited autopsies, clinical observations, and laboratory data suggest that high cytokine levels and a procoagulant state can precipitate acute respiratory distress syndrome and multi-organ dysfunction syndrome in critically ill patients. To complicate matters, comorbidities may affect the response to medical treatments currently in use, all of which are still in trial phase. Therapeutic plasma exchange (TPE) merits consideration in the treatment of critically ill COVID-19 patients and is an avenue for clinical trials to pursue. If efficacious, faster recovery of patients may lead to shorter intensive care unit stays and less time on mechanical ventilation. Herein, we briefly discuss some of the various approaches currently being investigated for the treatment of SARS-CoV-2 with a focus on potential benefits of TPE for selected critically ill patients.
- 15 July 2020
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 35 (9) , 827-835
Open AccessTherapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients
In the 5 months since initial reports of COVID-19 came to light, the death toll due to SARS-CoV-2 has rapidly increased. The morbidity and mortality of the infection varies based upon patient age, comorbid conditions, viral load, and the availability of effective treatments. Findings from limited autopsies, clinical observations, and laboratory data suggest that high cytokine levels and a procoagulant state can precipitate acute respiratory distress syndrome and multi-organ dysfunction syndrome in critically ill patients. To complicate matters, comorbidities may affect the response to medical treatments currently in use, all of which are still in trial phase. Therapeutic plasma exchange (TPE) merits consideration in the treatment of critically ill COVID-19 patients and is an avenue for clinical trials to pursue. If efficacious, faster recovery of patients may lead to shorter intensive care unit stays and less time on mechanical ventilation. Herein, we briefly discuss some of the various approaches currently being investigated for the treatment of SARS-CoV-2 with a focus on potential benefits of TPE for selected critically ill patients.